Organovo Holdings (STU:4OR1) Short-Term Capital Lease Obligation : €0.47 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings Short-Term Capital Lease Obligation?

Organovo Holdings's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.47 Mil.

Organovo Holdings's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (€0.47 Mil) to Dec. 2023 (€0.46 Mil) but then increased from Dec. 2023 (€0.46 Mil) to Mar. 2024 (€0.47 Mil).

Organovo Holdings's annual Short-Term Capital Lease Obligation increased from Mar. 2022 (€0.44 Mil) to Mar. 2023 (€0.46 Mil) and increased from Mar. 2023 (€0.46 Mil) to Mar. 2024 (€0.47 Mil).

Organovo Holdings Short-Term Capital Lease Obligation Historical Data

The historical data trend for Organovo Holdings's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Short-Term Capital Lease Obligation Chart

Organovo Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.44

0.46

0.47

Organovo Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.46	0.46	0.47	0.46	0.47

Organovo Holdings Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Organovo Holdings Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Organovo Holdings (STU:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (STU:4OR1) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ONVO:USA

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (STU:4OR1) Headlines

No Headlines